Dr. Michelangelo Certo qualified for a MSc in Pharmaceutical Chemistry and Technology cum laude in 2010 and a PhD in Cellular Biochemistry and Pharmacology in 2013 from the University of Calabria (Italy). Post-doc at the Centre of Preclinical and Translational Pharmacology, University of Calabria (2013-2015), he worked on the characterization of the interactions between the immune system and the brain subjected to ischemic injury for the identification of novel immunotherapeutics for stroke. In 2016 Michelangelo was awarded a Research Fellowship from the Italian Society of Pharmacology and he joined the University College London to apply his research to the field of chronic pain. In 2017 he moved to Barts and The London School of Medicine and Dentistry at Queen Mary, University of London, where he focused on the investigation of the metabolic control of immune cell effector functions and the implications of the metabolic dependence of immune responses in inflammatory conditions. In 2018 he joined the Institute of Inflammation and Ageing at the University of Birmingham as Senior Research Fellow in Metabolism and Inflammation to investigate the interconnections between metabolic and inflammatory pathways. His current research activities address the study of cellular and molecular mechanisms involved in the pathophysiology of chronic inflammatory diseases, such as atherosclerosis (BHF) and Sjogren's syndrome (MRC funded).